97028 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants
METHODS OF GENE THERAPY USING NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER
#2702Mutated voltage-gated sodium channel Naalpha subunit for identification of modulators
#2703Mutant smoothened and methods of using the same
#2704Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
#2705METHODS AND COMPOSITIONS FOR INHIBITING PROPAGATION OF VIRUSES USING RECOMBINANT TETHERIN CONSTRUCTS
#2706Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v
#2707Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof
#2708H-gated ion channel
#2709Chimeric NK receptor and methods for treating cancer
#2710Fn14/TRAIL fusion proteins and method of treating cancer
#2711NOVEL POLYPEPTIDE, CDNA ENCODING THE SAME, AND USE THEREOF
#2712Modified sodium iodide symporter proteins and uses thereof
#2713Antibody to SOST peptides
#2714COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#2715Compositions and methods for treating kidney disease
#2716T cell receptors and related materials and methods of use
#2717Complement receptor 1 and 2 fusion proteins
#2718COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS
#2719Therapeutic TREM-1 peptides
#2720Isolated nucleic acid molecules encoding bitter taste receptor polypeptides and fragments thereof
#2721Wise/Sost nucleic acid sequences and amino acid sequences
#2722COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS
#2723Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2)
#2724Nucleic acid encoding a T2R taste receptor
#2725Albumin binding peptide-mediated disease targeting
#2726Isoforms of human somatostatin receptor type 5
#2727METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF
#2728Antibodies to JTT-1 protein and cells secreting such antibodies
#2729Method for increasing the pool of Ngn3+ endocrine progenitor cells and pancreatic endocrine cell mass
#2730T2R taste receptors and genes encoding same
#2731System for screening agonists/antagonists of cellular signaling pathways
#2732Multiple-tumor aberrant growth genes
#2733MHC Multimers in Cancer Vaccines and Immune Monitoring
#2734Immunosuppression modulating compounds
#2735Serpentine transmembrane antigens expressed in human cancers and uses thereof
#2736Inhibitors of BCL-2
#2737CELL LINES EXPRESSING NaV AND METHODS OF USING THEM
#2738Recombinant Bone Marrow Stromal Antigen-2 in the Treatment of Autoimmune Diseases
#2739Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets
#2740Optically-based stimulation of target cells and modifications thereto
#2741PROSAPOSIN AS A NEUROTROPHIC FACTOR
#2742CPG RECEPTOR (CPG-R) AND METHODS RELATING THERETO
#2743CALCIUM SENSOR STIM1 AND THE PLATELET SOC CHANNEL ORAI1 (CRACM1) ARE ESSENTIAL FOR PATHOLOGICAL THROMBUS FORMATION
#2744Wnt Antagonists and Methods of Treatment and Screening
#2745Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
#2746Antibodies specific for sulfated sclerostin
#2747Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor
#2748Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
#2749Methods for identifying kremen polypeptide binding partners
#2750METHOD FOR TREATING SOLID TUMORS
#2751INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#2752ULBP2 polypeptides
#2753Albumin Fusion Proteins
#2754Proteoglycan splice variants as therapeutics and diagnostics for amyloid diseases
#2755Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
#2756Detection and treatment of non-dermal fibrosis
#2757Compositions and methods for the diagnosis and treatment of tumor
#2758HCV entry factor, Occludin
#2759Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
#2760Method of loading a crystallization device
#2761Crystal structure of human mitoNEET protein
#2762Modified Thromboxane A2 Receptor Promoter Sequence
#2763Ryanodine receptor polypeptides
#2764Multimeric constructs
#2765Compositions and methods for the treatment of tumor of hematopoietic origin
#2766Antibodies that bind to PSCA proteins for diagnosis of cancer
#2767In vitro methods of detecting cells sensitive to sweet tastants by detecting expression of hetero-oligomeric T1R2/T1R3 taste receptors
#2768SUPPRESSION OF CANCER
#2769High affinity NY-ESO T cell receptors
#2770Method of detecting endometrial cancer comprising measuring levels of fibrocystin-L
#2771T-cell receptor and nucleic acid encoding the receptor
#2772Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein
#2773Disease-Associated Antigens and Methods of Use Thereof
#2774Methods and compositions for diagnosing and treating diseases
#2775Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
#2776FOCAL CALCIUM CHANNEL MODULATION
#2777Engineered Listeria and methods of use thereof
#2778T1R3 nucleic acid fragments for use thereof as probes and for generating T1R specific antibodies
#2779Rage Fusion Proteins And Methods Of Use
#2780Mammalian sweet taste receptors
#2781ISOLATED MAMMALIAN MEMBRANE PROTEIN GENES; RELATED REAGENTS
#2782Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#2783Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands
#2784Method of reversing carboplatin resistance by inhibition of HGFIN
#2785LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#2786ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#2787Synthetic mimics of mammalian cell surface receptors: method and compositions
#2788HUMAN SALTY TASTE RECEPTOR AND METHODS OF MODULATING SALTY TASTE PERCEPTION
#2789TIKI1 AND TIKI2, WNT INHIBITORS
#2790NLRC5 AS A TARGET FOR IMMUNE THERAPY
#2791Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators
#2792Assays using chimeric T1R polypeptides for identifying putative taste modulatory compounds
#2793TREATMENT OF PAIN WITH GAP JUNCTION MODULATION COMPOUNDS
#2794Human Notch3 based fusion proteins as decoy inhibitors of Notch3 signaling
#2795Methods for reducing botulinum neurotoxin A toxicity
#2796Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases
#2797Use of inhibitors of leukotriene B4 receptor BLT2 for treating human cancers
#2798Compounds for stimulating P-glycoprotein function and uses thereof
#2799Methods of treating hypertension
#2800Targeted delivery of glycine receptors to excitable cells
#2801Use of bitter taste receptor to screen for compounds that offset the bitter taste of chlorogenic lactone containing coffee compositions
#2802Presenilin associated membrane protein (PAMP) and uses thereof
#2803Viral Therapeutic
#2804Photoreactive synthetic regulator of protein function and methods of use thereof
#2805T1R taste receptors and genes encoding same
#2806Cell lines expressing T1R2/T1R3 hetero-oligomeric taste receptors and assay system thereof for identification of taste compounds
#2807Assays that detect T1R expressing cells
#2808COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMATION
#2809T-cell antigen peptide from allergen for stimulation of IL-10 production
#2810COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#2811CHEMOSENSORY GENE FAMILY ENCODING GUSTATORY AND OLFACTORY RECEPTORS AND USES THEREOF
#2812TRANSGENIC MAMMALS AND CELL LINES FOR THE IDENTIFICATION OF GLUTAMATE TRANSPORTER MODULATORS
#2813Methods of detecting T1R2- and T1R3-expressing cells potentially sensitive to sweet tastants
#2814Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#2815Polypeptides and use thereof
#2816METHODS AND MATERIALS FOR PRODUCING TRANSGENIC ARTIODACTYLS
#2817PROSAPOSIN AS A NEUROTROPHIC FACTOR
#2818ARTERY- AND VEIN-SPECIFIC PROTEINS AND USES THEREFOR
#2819Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits
#2820Nucleic acids encoding RUP3 and methods of using same
#2821METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS
#2822Method and composition for crystallizing G protein-coupled receptors
#2823METHODS FOR P2RY5 MEDIATED REGULATION OF HAIR GROWTH AND MUTANTS THEREOF
#2824G PROTEIN COUPLED RECEPTORS AND USES THEREOF
#2825PEPTIDES CAPABLE OF MODULATING THE FUNCTION OF TIRC7
#2826CANINE TRANSIENT RECEPTOR POTENTIAL V2 (CTRPV2) AND METHODS OF SCREENING FOR TRPV2 CHANNEL MODULATORS
#2827Isolated bitter taste receptor polypeptides
#2828Methods and compositions for inhibition of neutrophil exocytosis
#2829Human G Protein-Coupled Receptors and Modulators Thereof for the Treatment of Metabolic-Related Disorders
#2830Bitter taste receptors
#2831P2X7 epitopes
#2832Molecular structure of RHD negative
#2833Method and composition for crystallizing G protein-coupled receptors
#2834LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE
#2835Markers of Induced Pluripotent Stem Cells
#2836Design and Use of Sortilin Specific Molecular Imaging Ligands
#2837Gaming system network and method for delivering gaming media
#2838CDH3 peptide and medicinal agent comprising the same
#2839LSR RECEPTOR, ITS ACTIVITY, ITS CLONING, AND ITS APPLICATIONS TO THE DIAGNOSIS, PREVENTION AND/OR TREATMENT OF OBESITY AND RELATED RISKS OR COMPLICATIONS
#2840NOVEL 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 AND 26908 MOLECULES AND USES THEREFOR
#2841Method and composition for crystallizing G protein-coupled receptors
#2842Specific ligands to sortilin
#2843FUNCTIONAL COMPLEMENTATION ASSAY FOR DEFINED GPCR OLIGOMERS
#2844Network access device and method to run a game application
#2845Gaming system network and method for delivering gaming media
#2846Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof
#2847SULFONYLUREA RECEPTOR AND MEANS FOR TREATING ISCHAEMIA
#2848hERG MUTANTS AND USES THEREOF
#2849Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1
#2850Polynucleotides and Polypeptides Encoding Receptors
#2851Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho
#2852Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders
#2853Genetically Modified Rat Models for Pharmacokinetics
#2854Method for selectively extracting membrane proteins using calixarenes
#2855Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer
#2856Megalin-based delivery of therapeutic compounds to the brain and other tissues
#2857NEURTURIN RECEPTOR
#2858IDENTIFICATION OF TUMOUR-ASSOCIATED CELL SURFACE ANTIGENS FOR DIAGNOSIS AND THERAPY
#2859ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION
#2860MODIFIED PICHIA STRAIN
#2861Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
#2862NOGO Receptor Homologs
#2863COMPENSATING FOR ATRIOVENTRICULAR BLOCK USING A NUCLEIC ACID ENCODING A SODIUM CHANNEL OR GAP JUNCTION PROTEIN
#2864Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)
#2865Dendritic cell marker and uses thereof
#2866Rage Fusion Proteins And Methods Of Use
#2867Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival
#2868Factor VIII polypeptide having factor VIII:C activity
#2869Cell division marker
#2870Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders
#2871Sodium channel protein type III α-subunit splice variant
#2872Reactivation of axon growth and recovery in chronic spinal cord injury
#2873Cell line, system and method for optical control of secondary messengers
#2874Human G-Protein Coupled Receptor (HETGQ23)
#2875Novel Protein for Binding Bacillus Thuringiensis Cry Toxins and Fragments of Cadherins for Enhancing Cry Toxicity Against Dipterans
#2876Antibodies for binding to non-functional P2Xreceptors in trimeric form
#2877Compositions and methods for the treatment of immune related diseases
#2878Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
#2879METHODS AND COMPOSITIONS FOR CELL-CYCLE REGULATION
#2880Methods of identifying modulators of GPR81 receptors
#2881MUTANT SODIUM CHANNEL NAV 1.7 AND METHODS RELATED THERETO
#2882Directed evolution and in vivo panning of virus vectors
#2883Membrane Associated Tumor Endothelium Markers
#2884IN VITRO METHODS FOR DETECTING RENAL CANCER
#2885PARTIAL T1R2 NUCLEIC ACID SEQUENCE, RECEPTOR PROTEIN AND ITS USE IN SCREENING ASSAYS
#2886BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF
#2887Marker genes for regulatory T cells from human blood
#2888Non-functional P2Xreceptor
#2889Variants derived from ActRIIB and uses therefor
#2890Compositions and methods for modulating dopamine neurotransmission
#2891Proteins and methods for modulating cell activity
#2892METHODS AND SYSTEMS FOR ANNOTATING BIOMOLECULAR SEQUENCES
#2893Methods for regulation of stem cells
#2894Upregulation of opioid receptors for management
#2895Emergence of a R-type CA2+ channel (CAV 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage
#2896H-gated ion channel
#2897Transferrin fusion protein libraries
#2898Compositions and Methods for Expressing In-Frame Multimeric Proteins
#2899Ryanodine receptor polypeptides
#2900PORCINE UMAMI TASTE RECEPTORS AND USES THEREFOR
#2901T1R3 binding assays
#2902Methods of identifying compounds that bind TANGO240
#2903Means and Methods for Influencing Electrical Activity of Cells
#2904ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS
#2905NICOTINIC ACID RECEPTOR LIGANDS
#2906COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC
#2907ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF
#2908T-cell having a T-cell receptor that recognizes epitope HBC18-27 of hepatitis B viral core antigen
#2909Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
#2910Methods of identifying compounds that bind TANGO509
#2911Prostate cancer diagnosis and treatment
#2912METHODS AND SYSTEMS FOR PRODUCING NANOLIPOPROTEIN PARTICLES
#2913Compositions and methods for promoting wound healing and tissue regeneration
#2914Polypeptides involved in immune response
#2915TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION
#2916Methods of identifying modulators of bitter taste using hT2R50 receptors
#2917CACNB2 nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death
#2918Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof
#2919Methods for off-the-shelf tumor immunotherapy using allogeneic T-cell precursors
#2920METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS
#2921CADHERIN-11 ANTAGONISTS AND METHODS FOR THE TREATMENT OF INFLAMMATORY JOINT DISORDERS
#2922COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#2923NOVEL CHIMERIC PROTEINS
#2924COMPOSITION FOR TREATMENT OF ERECTILE DYSFUNCTION
#2925PLATELET GLYCOPROTEIN IB ALPHA VARIANT FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#2926Molecular Interactions in Neurons
#2927COMPLEXING SYSTEM
#2928High affinity NY-ESO T cell receptor
#2929Genetically Modified Rat Models for Drug Metabolism
#2930Compositions and methods modulating MG29 for the treatment of diabetes
#2931USES OF ANTIBODIES TO MAMMALIAN DC LANGERHANS CELL ANTIGEN
#2932Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
#2933PROSPECTIVE IDENTIFICATION AND CHARACTERIZATION OF BREAST CANCER STEM CELLS
#2934Human G-Protein Coupled Receptor
#2935Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus
#2936IMMUNOGLOBULIN FUSION PROTEIN FORMULATIONS
#2937Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
#2938Methods and compositions for obtaining high-resolution crystals of membrane proteins
#2939Transgenic Animal Model of Cancer and Methods of Use
#2940Nucleic acids that encode sodium channel
#2941RAP variants for drug delivery and methods of use thereof
#2942Activated amino- and carboxy-terminal forms of Notch
#2943SOLUBILIZATION AND STUDY OF MEMBRANE PROTEINS
#2944Screening
#2945Antibodies specific for ZNT8
#2946Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
#2947Homing peptide for tumor vasculature
#2948CRYSTALLINE VAP-1 AND USES THEREOF
#2949Sphingosine 1-phosphate receptor gene, SPPR
#2950Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels
#2951TRPC6 involved in glomerulonephritis
#2952Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor
#2953Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof
#2954Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
#2955Multidrug resistance-associated polypeptide
#2956Tweak receptor
#2957Inhibition of inflammation using antagonists of MUC1
#2958Targeting complement factor H for treatment of diseases
#2959Isolation of unknown rearranged T-cell receptors from single cells
#2960NUCLEIC ACIDS ENCODING T2R, A NOVEL FAMILY OF TASTE RECEPTORS
#2961High affinity NY-ESO T cell receptors
#2962DDR1-mediated cell purification of pancreatic endocrine cells through their progenitors
#2963Method and composition for crystallizing G protein-coupled receptors
#2964Methods and compositions for treating asthma
#2965Albumin fusion proteins
#2966Dopaminergic neuron progenitor cell marker 187A5
#2967Toll-like receptor 3 antagonists
#2968Compositions of humanized notch fusion proteins and methods of treatment
#2969Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders
#2970CHEMICAL SENSOR HAVING SENSITIVE FILM IMITATING OLFACTORY RECEPTOR
#2971Method for the separation of cells
#2972MODULATORS AND MODULATION OF THE INTERACTION BETWEEN RGM AND NEOGENIN
#2973C5a Receptor Antagonists
#2974CELL LINES EXPRESSING GABA RECEPTOR AND METHODS USING THEM
#2975REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS
#2976HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN KRTCAP3 AND LIGANDS FOR THE PROTEIN KRTCAP3
#2977COMPLEXES OF TRPC DOMAINS AND SESTD1 DOMAINS AND METHODS AND USES INVOLVING THE SAME
#2978Assays using chimeric T1R3 taste receptor polypeptides
#2979ORGANIC COMPOUNDS
#2980Methods for suppressing Toll-like Receptor 4 (TLR4) function using TLR14 antagonists
#2981Regulated apoptosis
#2982AGENT AND METHOD FOR DIAGNOSIS ON THE OCCURRENCE OF ALZHEIMER'S DISEASE OR THE TENDENCY TO DEVELOP ALZHEIMER'S DISEASE
#2983STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#2984Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
#2985METHODS OF USING CADHERIN 11 (CDH11) ANTAGONISTS
#2986Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest
#2987Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
#2988Transgenic non-human animals for pharmacological and toxicological studies
#2989Methods for reducing CD36 expression
#2990Nucleic acid molecules encoding soluble frizzled (FZD) receptors
#2991NOVEL COMPOSITIONS AND METHODS IN CANCER WITH ALTERED EXPRESSION OF KCNJ9
#2992Protection of virus particles from phagocytosis by expression of CD47
#2993Peptides
#2994VIRAL VECTOR SYSTEM, A COMPOSITION COMPRISING THE VIRAL VECTOR SYSTEM AND ITS USE
#2995CELL LINES AND METHODS FOR MAKING AND USING THEM (As Amended)
#2996PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF
#2997CHIMERIC HUMAN SWEET-UMAMI AND UMAMI-SWEET TASTE RECEPTORS
#2998ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
#2999HIV VPR-specific T cell receptors
#3000DCL-1 AND USES THEREOF